ResMed, Inc. (RMD)
228.35
-0.84
(-0.37%)
USD |
NYSE |
Sep 04, 16:00
228.32
-0.03
(-0.01%)
After-Hours: 20:00
ResMed Research and Development Expense (Quarterly) : 105.73M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 105.73M |
| March 31, 2026 | 94.27M |
| December 31, 2025 | 90.97M |
| September 30, 2025 | 87.32M |
| June 30, 2025 | 86.44M |
| March 31, 2025 | 83.94M |
| December 31, 2024 | 81.37M |
| September 30, 2024 | 79.52M |
| June 30, 2024 | 80.86M |
| March 31, 2024 | 77.07M |
| December 31, 2023 | 73.88M |
| September 30, 2023 | 75.71M |
| June 30, 2023 | 78.14M |
| March 31, 2023 | 76.44M |
| December 31, 2022 | 69.87M |
| September 30, 2022 | 63.19M |
| June 30, 2022 | 64.32M |
| March 31, 2022 | 66.80M |
| December 31, 2021 | 62.51M |
| September 30, 2021 | 59.95M |
| June 30, 2021 | 59.88M |
| March 31, 2021 | 55.94M |
| December 31, 2020 | 54.94M |
| September 30, 2020 | 54.53M |
| June 30, 2020 | 52.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 51.45M |
| December 31, 2019 | 49.94M |
| September 30, 2019 | 48.03M |
| June 30, 2019 | 51.14M |
| March 31, 2019 | 47.61M |
| December 31, 2018 | 43.11M |
| September 30, 2018 | 38.79M |
| June 30, 2018 | 39.66M |
| March 31, 2018 | 37.43M |
| December 31, 2017 | 40.64M |
| September 30, 2017 | 37.42M |
| June 30, 2017 | 36.71M |
| March 31, 2017 | 35.13M |
| December 31, 2016 | 38.19M |
| September 30, 2016 | 34.45M |
| June 30, 2016 | 34.38M |
| March 31, 2016 | 28.11M |
| December 31, 2015 | 28.97M |
| September 30, 2015 | 27.19M |
| June 30, 2015 | 28.52M |
| March 31, 2015 | 27.02M |
| December 31, 2014 | 29.29M |
| September 30, 2014 | 30.02M |
| June 30, 2014 | 31.80M |
| March 31, 2014 | 29.53M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Koninklijke Philips NV | 562.75M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| Rockwell Medical, Inc. | 0.04M |